InflaRx (IFRX) Liabilities and Shareholders Equity (2016 - 2026)

InflaRx has disclosed Liabilities and Shareholders Equity across 11 years of filings, most recently posting $57.2 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $57.2 million, down 37.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $280.8 million (down 22.09% YoY), and the FY2025 annual result was $64.3 million, down 20.88% from the prior year.
• Liabilities and Shareholders Equity came in at $57.2 million for Q1 2026 at InflaRx, down from $64.3 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $144.8 million in Q2 2023 to a low of $57.2 million in Q1 2026.
• The 5-year median for Liabilities and Shareholders Equity is $100.2 million (2024), against an average of $102.0 million.
• Across the five-year window, Liabilities and Shareholders Equity advanced 25.81% in 2023 and sank 37.91% in 2024, its largest moves.
• InflaRx's Liabilities and Shareholders Equity stood at $104.5 million in 2022, then advanced by 23.8% to $129.3 million in 2023, then plunged by 37.19% to $81.2 million in 2024, then declined by 20.88% to $64.3 million in 2025, then fell by 10.95% to $57.2 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $57.2 million (Q1 2026), $64.3 million (Q4 2025), and $76.2 million (Q3 2025), per Business Quant data.